The Laupheim Biotech Days – formally known as Laupheimer Zelltage – provide a unique platform for the international exchange of knowledge, ideas and expertise. Held every two years, it focus on different topics in the field of biotechnology. A comprehensive overview is given and experts discuss cutting-edge technologies and techniques. Next year the 4th Laupheim Biotech Days will take place on June 13 to 14, 2016.
Change reflects the company’s evolution to a strategic partner, delivering data-driven digital and mobile health engagement campaigns that empower better decisions and drive business results.
The coldest place on earth is unsurprisingly the Antarctic, with temperatures regularly reaching minus 70 degrees Celsius. In research and industrial settings alike, the need for storing products and samples at ultra-low temperatures is constantly increasing. We are now able to replicate these bone-chilling temperatures in an innovative, efficient storage solution.
The stem cell disease model specialists join Chesterford’s Science Village community, taking space within the Park’s prestigious, ‘plug and play’ laboratory accommodation.
The stem cell disease model specialists, consolidate and ensure further commercial success by the recruitment of Sanj Kumar as Chief Business Officer.
New England Biolabs® (NEB®) announces the release of the NEBNext Library Quant Kit for Illumina®, a qPCR-based solution for accurate next generation sequencing library quantitation. This kit offers several improvements over other commercially available library quantitation methods, including greater accuracy and, consequently, higher correlation with cluster numbers, higher reproducibility, a more convenient protocol and supplied kit components.
New England Biolabs® (NEB) today announced the release of the NEBNext Ultra II DNA Library Prep Kit for Illumina® next generation sequencing systems. The new Ultra II kit substantially improves upon its predecessor to produce libraries of both higher quality and higher yield from a variety of sample types, including challenging ones, such as formalin-fixed, paraffin-embedded (FFPE) samples and those containing low amounts of input DNA.
With the goal of better serving its customers in more regulated markets, New England Biolabs (NEB®) today announced plans to build capacity for manufacturing enzymes and other reagents according to good manufacturing practices (GMP), which are standards for materials involved in the manufacture of human therapeutics and molecular diagnostics. The plans include the construction of a new 30,000 s.f., state-of-the-art, fully GMP-compliant cleanroom facility, to be located near NEB’s Ipswich, MA headquarters. Construction is scheduled to begin in 2015, and the site is expected to be
commissioned, validated and fully operational by early 2017.
New England Biolabs (NEB®) announces a novel DNA repair reagent aimed at helping to address the historically intractable challenge of sequencing DNA from archival, formalin-fixed, paraffin-embedded (FFPE) tissue samples. Together with its NEBNext line of next-generation sequencing library preparation reagents, NEB now offers a complete solution for preparing DNA from FFPE samples for sequencing on both the Illumina® and Ion Torrent™ platforms.
Woodley Equipment is exhibiting at the 14th Annual Partnerships in Clinical Trials Congress, which is taking place on 18th and 19th November 2015 at CCH Congress Center, Hamburg, Germany.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.